Clinical features of novel coronavirus infection (omicron variant) in patients with end-stage kidney disease

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Before the emergence of the omicron variant, novel coronavirus infection in patients with end-stage kidney disease was characterized by a severe course and poor prognosis. Since January 2022, the omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the most prevalent strain in Russia. This strain is associated with uncommon virus-induced lung injury and significantly lower hospitalization and mortality rates compared to previous variants.

AIM: This study aimed to assess the course of the omicron variant of SARS-CoV-2 in patients with end-stage kidney disease.

METHODS: The retrospective cohort study included 33 medical records of patients with end-stage kidney disease who had been treated for novel coronavirus infection at the Infectious Diseases Clinic of Kirov Military Medical Academy and Botkin Clinical Infectious Diseases Hospital between January 2022 and February 2024. Following a comprehensive analysis of the medical records, the patients were divided into two groups. Group 1 included 12 patients with novel coronavirus infection in the form of acute respiratory viral infection without lung involvement. Group 2 comprised 21 patients with virus-induced lung injury.

RESULTS: The omicron variant of SARS-CoV-2 frequently caused lung injury, including acute respiratory failure, in patients with end-stage kidney disease. The early stages of inpatient treatment for this group of patients were characterized by fever (≥ 37.2°C), tachycardia (≥ 90 bpm), National Early Warning Score ≥ 4, and prolonged viral shedding (12 [10; 18] vs 9 [7,5; 9,5] days, p = 0.002).

CONCLUSION: The high prevalence of comorbidities and frequent occurrence of virus-induced lung injury leading to acute respiratory failure underscore a unique cohort of patients with end-stage kidney disease requiring programmed hemodialysis and highlight the ongoing challenge of novel coronavirus infection, even during the spread of the omicron variant of SARS-CoV-2.

Full Text

Restricted Access

About the authors

Panteley I. Miklush

Kirov Military Medical Academy

Author for correspondence.
Email: vmeda-nio@mil.ru
ORCID iD: 0000-0002-5668-462X
SPIN-code: 1599-4487

Adjunct

Russian Federation, Saint Petersburg

Konstantin V. Zhdanov

Kirov Military Medical Academy; Children’s Scientific and Clinical Center of Infectious Diseases; Saint Petersburg State University

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0002-3679-1874
SPIN-code: 7895-2075

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg; Saint Petersburg; Saint Petersburg

Andrey N. Belskikh

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0002-0421-3797
SPIN-code: 7764-0930

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Konstantin V. Kozlov

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0002-4398-7525
SPIN-code: 7927-9076

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Anatoly K. Shvedov

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0009-0006-1586-3564
SPIN-code: 6258-2587

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Mikhail V. Zakharov

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-6549-3991
SPIN-code: 4732-9877

MD, Cand. Sci. (Medicine), Associate Professor

Russian Federation, Saint Petersburg

Nikolay I. L'vov

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0003-4254-229X
SPIN-code: 8414-8612

MD, Dr. Sci. (Medicine), Associate Professor

Russian Federation, Saint Petersburg

Natalia Yu. Sopova

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0009-0004-0747-5540
SPIN-code: 5780-9082
Russian Federation, Saint Petersburg

Yuri I. Lyashenko

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-9163-7012
SPIN-code: 5404-0988

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Alexandra Ya. Komarova

Saint Petersburg State University

Email: vmeda-nio@mil.ru
ORCID iD: 0000-0001-6753-9180
SPIN-code: 6999-5874

MD, Cand. Sci. (Medicine), Associate Professor

Russian Federation, Saint Petersburg

Diana Yu. Korneenkova

Kirov Military Medical Academy

Email: vmeda-nio@mil.ru
ORCID iD: 0009-0005-9709-0296

Cadet

Russian Federation, Saint Petersburg

References

  1. Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020;31(7):1387–1397. doi: 10.1681/ASN.2020030354
  2. Goodlad C, Davenport A. The changing pattern of COVID-19 infection in haemodialysis and peritoneal dialysis patients. Artif Organs. 2023;47(7): 1202–1207. doi: 10.1111/aor.14526
  3. Frolova NF, Kim IG, Ushakova AI, et al. COVID-19 in hemodialysis patients. Infectious Diseases: News, Opinions, Training. 2021;10(1):14–23. doi: 10.33029/2305-3496-2021-10-1-14-23 EDN: RYXXQM
  4. Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6): 1530–1539. doi: 10.1016/j.kint.2020.07.030
  5. Guidotti R, Pruijm M, Ambühl PM. COVID-19 pandemic in dialysis patients: The swiss experience. Front Public Health. 2022;10:795701. doi: 10.3389/fpubh.2022.795701
  6. Yavuz D, Karagöz Özen DS, Demirağ MD. COVID-19: mortality rates of patients on hemodialysis and peritoneal dialysis. Int Urol Nephrol. 2022;54(10):2713–2718. doi: 10.1007/s11255-022-03193-6
  7. Andreenko AA, Andrejchuk JuV, Arsent’ev VG, et al. Infection caused by SARS-CoV-2. Krjukov EV, editor. Saint-Petersburg: Kirov Military Medical Academy; 2023. 260 p. EDN: QFKFPF (In Russ.)
  8. Chawki S, Buchard A, Sakhi H, et al. Long-term impact of COVID-19 among maintenance haemodialysis patients. Clin Kidney J. 2021;15(2): 262–268. doi: 10.1093/ckj/sfab166
  9. O’Sullivan ED, Lees JS, Howie KL, et al. Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease. Nephrology (Carlton). 2021;26(4):328–332. doi: 10.1111/nep.13844
  10. Shaikh A, Zeldis E, Campbell KN, Chan L. Prolonged SARS-CoV-2 viral RNA shedding and IgG antibody response to SARS-CoV-2 in patients on hemodialysis. Clin J Am Soc Nephrol. 2021;16(2):290–292. doi: 10.2215/CJN.11120720
  11. L’vov NI. ARVI and NKVI: from general concepts to the definition of nosological and clinical forms of diseases. In: Thesis’s of the V International forum: «Virology days»; 30 Sept 2024 – 01 Okt 2024; Saint-Petersburg. Saint-Petersburg: St. Petersburg public organization «Man and his health»; 2024. P. 67–68. (In Russ.)
  12. Akimkin VG, Popova AY, Khafizov KF, et al. COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants. Journal of microbiology, epidemiology and immunobiology. 2022;99(4):381–396. doi: 10.36233/0372-9311-295 EDN: KVULAS
  13. Arabi M, Al-Najjar Y, Mhaimeed N, et al. Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review. J Cell Mol Med. 2023;27(11):1443–1464. doi: 10.1111/jcmm.17747
  14. Ilyin AP, Gurevich KYa, Denisov AYu, et al. The management of medical care with dialysis methods in outpatients during the COVID-19 pandemic. Nephrology and Dialysis. 2022;24(2):301–321. doi: 10.28996/2618-9801-2022-2-301-321 EDN: LWMQDN
  15. Zhdanov KV, Kozlov KV, Bulankov YuI, et al. Optimization of diagnosis of SARS-CoV-2 infection using polymerase chain reaction in a large multi-specialty hospital. Bulletin of the Russian Military Medical Academy. 2020;22(2):7–10. doi: 10.17816/brmma50036 EDN: FQVQWY
  16. Ministry of Health of the Russian Federation. Temporary methodological recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version-18 (26.10.2023). Moscow: Ministry of Health of the Russian Federation; 2023. 250 p. (In Russ.)
  17. Unguryanu TN, Grjibovski AM. Brief recommendations on description, analysis and presentation of data in scientific papers. Human ecology. 2011;(5):55–60. EDN: NRDBMN (In Russ.)
  18. Kryukov EV, Zhdanov KV, Kozlov KV, et al. Electron microscopic changes in the nasal membrane of patients with COVID-19 depending on the clinical form and the period of the disease. Journal Infectology. 2021;13(2):5–13. doi: 10.22625/2072-6732-2021-13-2-5-13 EDN: UYWDWK
  19. Platonova TA, Semenenko TA, Golubkova AA, et al. Prognostic criteria for the development of severe clinical forms of COVID-19 in medical organization workers. Infectious Diseases: News, Opinions, Training. 2022;11(4):19–29. doi: 10.33029/2305-3496-2022-11-4-19-29 EDN: GZNBLD
  20. Lalueza A, Lora-Tamayo J, de la Calle C, et al. The early use of sepsis scores to predict respiratory failure and mortality in non-ICU patients with COVID-19. Rev Clin Esp (Barc). 2022;222(5):293–298. doi: 10.1016/j.rceng.2020.10.004

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig 1. Clinical variants of COVID-19 course in patients of both groups. Blue colour - mild course, red - moderate, green - severe.

Download (113KB)
3. Fig. 2. Elimination of SARS-CoV-2 ribonucleic acid in patients with terminal chronic kidney disease on renal replacement therapy.

Download (113KB)
4. Fig. 3. Frequency of detection of chronic diseases in patients suffering from terminal chronic kidney disease in comparison groups.

Download (239KB)

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77762 от 10.02.2020.